To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1
NCT00100074 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2017-01-11
Summary
To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.
Conditions
- Amphetamine-Related Disorders
Interventions
- DRUG
-
Lobeline
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Reese Jones, M.D. · Langley Porter Psychiatric Institute
Study Design
- Purpose
- DIAGNOSTIC
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-09-30
- Completion
- 2005-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
NCT06721494 ·Status: RECRUITING ·Phase: PHASE2
-
Open-Label Disulfiram for Methamphetamine Dependence
NCT00731133 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of Modafinil for Methamphetamine Dependence
NCT00569374 ·Status: COMPLETED ·Phase: PHASE2
-
Topiramate for the Treatment of Methamphetamine Dependence - 1
NCT00345371 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
NCT00136734 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
NCT00218348 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Pharmacokinetic Study of CPP-115
NCT01493596 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment With Lorcaserin for Cocaine Use: The TLC Study
NCT03192995 ·Status: TERMINATED ·Phase: PHASE2
-
Trial of Modafinil for Methamphetamine Dependence
NCT00123370 ·Status: UNKNOWN ·Phase: PHASE2
-
Rivastigmine as a Treatment for Methamphetamine Dependence
NCT01073319 ·Status: COMPLETED ·Phase: PHASE1
-
Methylphenidate to Treat Methamphetamine Dependence
NCT01044238 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
NCT00033072 ·Status: UNKNOWN ·Phase: PHASE1
-
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
NCT00713479 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809
NCT00437632 ·Status: COMPLETED ·Phase: PHASE1
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Methamphetamine Abuse Treatment in Patients With AIDS - 1
NCT00000321 ·Status: COMPLETED ·Phase: PHASE4
-
A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1
NCT00033124 ·Status: UNKNOWN ·Phase: PHASE2
-
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
NCT00809835 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer
NCT02383043 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Varenicline as a Treatment for Methamphetamine Dependence
NCT01571167 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers
NCT00656357 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
NCT00000349 ·Status: UNKNOWN ·Phase: PHASE1
-
Clavulanic Acid for the Treatment of Cocaine Use Disorder
NCT05562349 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334
NCT00513279 ·Status: COMPLETED ·Phase: PHASE1